Sign In

Michael Shpigelmacher

Co-founder, CEO at Bionaut Labs. We're hiring!

Professional Background

Michael Shpigelmacher is a dynamic entrepreneur and visionary leader in the field of biotechnology and robotics. He is the driving force behind the revolutionary startup, Bionaut Labs, where he serves as Co-Founder and CEO. At Bionaut Labs, Michael leads the development of therapeutic remote-controlled micro-robots, known as Bionauts. These groundbreaking micro-robots are designed to navigate safely and precisely to hard-to-reach locations within the human body, enabling targeted delivery of medical treatments where they are most needed. The company's primary focus is on applications in the Central Nervous System, including innovative treatments for the brain and spinal cord.

Before embarking on his entrepreneurial journey, Michael accumulated vast experience in the financial sector as a Senior Investment Researcher at PDT Partners, a firm formerly part of Morgan Stanley. During his six years there, he excelled in creating proprietary investment strategies leveraging artificial intelligence to achieve sophisticated financial outcomes. His expertise in AI and investment management has been a game-changer for the firm, positioning them competitively in the capital markets.

Michael's impressive career also includes a significant tenure at McKinsey & Company, where he worked as an Engagement Manager. In this role, he led a team of talented consultants focused on corporate strategy, operations, investment strategy, and risk management. His impactful consulting work primarily targeted clients in the healthcare and financial sectors, helping them address complex challenges and implement transformative strategies.

Earlier in his career, Michael was instrumental in the founding of PrimeSense, a company renowned for developing the technology behind the Xbox Kinect. PrimeSense was eventually acquired by Apple, a testament to its groundbreaking innovations and success in the tech industry. Additionally, he spent six years as a Senior Product Manager at a sophisticated governmental R&D organization, leading a team of over 20 skilled engineers and researchers in managing complex product developments that met tough client requirements.

Education and Achievements

Michael Shpigelmacher's educational background is as illustrious as his professional trajectory. He holds an MBA with a focus on Finance, Entrepreneurship, and Strategy from Columbia Business School, where he honed not only his entrepreneurial skills but also deepened his understanding of financial analysis and market strategies.

Furthermore, Michael earned a Master of Science degree in Applied Mathematics and Computer Science from the prestigious Weizmann Institute of Science. This academic foundation has empowered him to integrate rigorous mathematical frameworks into his entrepreneurial ventures, enabling the development of sophisticated technological solutions.

In addition to his master's degree, Michael attained dual Bachelor of Science degrees in Physics and Computer Science from The Hebrew University of Jerusalem. These comprehensive studies provided him with a deep technical and scientific understanding, equipping him with the tools necessary to tackle multifaceted problems in both the technological and medical fields.

Achievements

Michael's career has been marked by numerous achievements that speak to his expertise and commitment to innovation. As the CEO and co-founder of Bionaut Labs, he is at the forefront of developing micro-robots that are set to revolutionize medical treatment by providing precision therapy in the Central Nervous System. This work not only showcases his entrepreneurial spirit but also reflects his deep commitment to advancing healthcare through technology.

In the investment sector, his tenure at PDT Partners was characterized by the successful creation of AI-driven investment strategies that enhanced the firm's portfolio management capabilities. Michael's ability to synthesize complex data and translate it into actionable insights has fortified his reputation as a leader in investment management.

At McKinsey & Company, he played a pivotal role in guiding corporate strategy for various clients, further enhancing their operational effectiveness and competitiveness. His strategic insights and leadership facilitated transformational changes, allowing organizations to optimize their operations and investment strategies.

Michael's early contributions at PrimeSense underscore his technological prowess and innovative thinking. His work in the development of the technology that powered the Xbox Kinect is a notable highlight and has earned him significant recognition in the tech landscape.

Overall, Michael Shpigelmacher stands out as a multifaceted leader and innovator, bridging the realms of biotechnology, AI, and investment management with exceptional success.

tags':['entrepreneur','biotechnology','robotics','AI','therapeutic micro-robots','startup leader','PDT Partners','investment strategies

Highlights

Nov 27 · linkedin

Excited to share the news about our round B and this nice article in the Financial Times

Michael Shpigelmacher
Add to my network

Location

Los Angeles, California, United States